Baraniak, Ilona <br/><br/>
Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation.  [electronic resource] 

 -  EBioMedicine  Dec 2019 
 - 45-54 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2352-3964 
<br/><br/><label>Standard No.: </label>10.1016/j.ebiom.2019.11.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic<br/>Antibodies, Neutralizing--blood<br/>Antibodies, Viral--blood<br/>Clinical Trials, Phase II as Topic<br/>Cytomegalovirus--immunology<br/>Cytomegalovirus Infections--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Humans<br/>Immunization, Secondary<br/>Immunocompromised Host<br/>Neutralization Tests<br/>Organ Transplantation--adverse effects<br/>Polysorbates<br/>Randomized Controlled Trials as Topic<br/>Squalene<br/>Time Factors<br/>Vaccination<br/>Viral Envelope Proteins--immunology<br/>Viral Vaccines--administration & dosage<br/>Viremia--prevention & control